These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2441220)

  • 1. Viral challenge in leprosy: viraemia, interferon, and specific antibody production.
    Gelber RH; Gooi HC; Porterfield JS; Lam SK; Rees RJ
    Lepr Rev; 1987 Jun; 58(2):155-64. PubMed ID: 2441220
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection.
    Reinhardt B; Jaspert R; Niedrig M; Kostner C; L'age-Stehr J
    J Med Virol; 1998 Oct; 56(2):159-67. PubMed ID: 9746073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous vaccination against cholera and yellow fever.
    Felsenfeld O; Wolf RH; Gyr K; Grant LS; Dutta NK
    Lancet; 1973 Mar; 1(7801):457-8. PubMed ID: 4120368
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to mycobacteria in human tuberculosis. II. Response to nine defined mycobacterial antigens with evidence for an antibody common to tuberculosis and lepromatous leprosy.
    Kaplan MH; Chase MW
    J Infect Dis; 1980 Dec; 142(6):835-43. PubMed ID: 6780633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever vaccine.
    Arya SC
    Emerg Infect Dis; 1999; 5(3):487-9. PubMed ID: 10341198
    [No Abstract]   [Full Text] [Related]  

  • 6. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
    Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
    Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever vaccine and egg allergy.
    Mosimann B; Stoll B; Francillon C; Pécoud A
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):1064. PubMed ID: 7751510
    [No Abstract]   [Full Text] [Related]  

  • 8. Yellow fever, 1996-1997. Part II.
    Wkly Epidemiol Rec; 1998 Nov; 73(47):370-2. PubMed ID: 9844551
    [No Abstract]   [Full Text] [Related]  

  • 9. Yellow fever vaccines.
    Barrett AD
    Biologicals; 1997 Mar; 25(1):17-25. PubMed ID: 9167005
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
    Charerntantanakul W; Pongjaroenkit S
    Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
    Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937).
    Theiler M; Smith HH
    Rev Med Virol; 2000; 10(1):6-16; discussion 3-5. PubMed ID: 10654001
    [No Abstract]   [Full Text] [Related]  

  • 14. Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy.
    Yong AJ; Grange JM; Tee RD; Beck JS; Bothamley GH; Kemeny DM; Kardjito T
    Tubercle; 1989 Dec; 70(4):273-9. PubMed ID: 2516671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy. 3. A comparison of IgA and IgM immunoproteins of patients with pulmonary tuberculosis and leprosy.
    Lim SD; Fusaro RM
    Int J Lepr Other Mycobact Dis; 1967; 35(3):361-5. PubMed ID: 4195464
    [No Abstract]   [Full Text] [Related]  

  • 16. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.
    WHEELOCK EF; SIBLEY WA
    N Engl J Med; 1965 Jul; 273():194-8. PubMed ID: 14306335
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amarillic hepatitis and diagnosis of the yellow fever].
    TORRES CM
    Schweiz Z Pathol Bakteriol; 1953; 16(3):522-36. PubMed ID: 13101742
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on viral interference induced by rinderpest virus: 4. Induction of circulating interferon and antibodies in buffaloes following inoculation with tissue culture rinderpest vaccine (TCRV) virus.
    Hussain SF; Rweyemamu MM; Kaminjolo JS; Akhtar AS; Mugera GM
    Bull Anim Health Prod Afr; 1982 Mar; 30(1):7-10. PubMed ID: 6194837
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine.
    Stefano I; Sato HK; Pannuti CS; Omoto TM; Mann G; Freire MS; Yamamura AM; Vasconcelos PF; Oselka GW; Weckx LW; Salgado MF; Noale LF; Souza VA
    Vaccine; 1999 Mar; 17(9-10):1042-6. PubMed ID: 10195613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.